Symbols

ALLR

Allarity·NASDAQ

--(--)

ALLR Profile

Allarity Therapeutics, Inc.

A clinical-stage biopharmaceutical company engages in developing oncology therapeutics

Industry

Pharmaceutical

Established Date

04/06/2021

Listing Date

12/21/2021

Exchange

NASDAQ Stock Exchange

Full-time Employees

Fiscal Year Ends

12-31

Website

www.allarity.com

Security Type

Common stock

Office address

123 E. Tarpon Ave. Tarpon Springs FL 34689

Business

Introduction

Allarity Therapeutics, Inc., was incorporated in Delaware on April 6, 2021. The company is a clinical-stage precision medicine pharmaceutical company focused on developing anticancer therapies using its drug response prediction platform. Its lead drug candidate, stenoparib, is a dual PARP/tankyrase inhibitor being developed for platinum-resistant ovarian cancer and small cell lung cancer, along with companion diagnostic reagents to identify patients who may benefit.